WTW stock holds as 2025 revenue and profit metrics frame the outlook

WTW (US9663871021) is framed by its latest reported 2025 operating metrics, including revenue of $9.86 billion, adjusted EBITDA of $2.31 billion, and diluted adjusted EPS of $16.17. Those figures matter because they provide the last full-year baseline for Willis Towers Watson PLC before the next earnings update and they show how the company’s profitability compares with its scale.

Revenue and margin base

The 2025 revenue figure of $9.86 billion gives a concrete scale reference for the business, while adjusted EBITDA of $2.31 billion points to an adjusted EBITDA margin of about 23.4%. Diluted adjusted EPS of $16.17 adds another profit measure for the same period, helping investors compare the company’s operating leverage with its top line.

That is a useful lens for a diversified insurance broker and consultant, because the earnings profile is driven less by single-product swings and more by recurring service demand, restructuring discipline, and fee growth across the portfolio. The year-over-year comparison is embedded in the full-year numbers themselves and is the most relevant way to read the latest reported baseline.

2025 numbers set the tone

WTW’s reported 2025 revenue of $9.86 billion and adjusted EBITDA of $2.31 billion are the key headline metrics to carry forward into the next reporting cycle. With diluted adjusted EPS at $16.17, the company has a three-part earnings profile that combines scale, margin, and per-share profitability.

For market readers, the central question is whether the next set of results can extend that pattern without a material change in cost discipline. The existing 2025 figures already give a measurable reference point, and the next release will be judged against that base rather than against a vague narrative about growth.

WTW stock and the service mix

WTW’s services span health, wealth, career, and risk advisory work, and that mix is one reason the business can carry a large revenue base without relying on one product line. The latest full-year figures show how that model translates into earnings: revenue of $9.86 billion, adjusted EBITDA of $2.31 billion, and diluted adjusted EPS of $16.17 in 2025.

That structure also explains why investors often focus on margin stability rather than simple revenue growth. A company with this profile can post slower top-line change and still create value if it keeps adjusted EBITDA and EPS moving in the right direction.

Market value focus

WTW stock trades on the Nasdaq, and the most recent dated market context should be read alongside the company’s 2025 financial baseline. The shares are typically assessed against the scale of the business, the margin profile, and the next reporting date rather than against a single product catalyst.

As a result, the stock story is less about a one-day headline and more about whether the company can maintain its 2025 earnings profile into 2026. Revenue of $9.86 billion, adjusted EBITDA of $2.31 billion, and diluted adjusted EPS of $16.17 remain the cleanest numerical anchors for that view.

Advisory and risk exposure

The advisory side of WTW matters because it links consulting demand to broader corporate spending on benefits, talent, and risk management. That link helps explain why the company’s 2025 adjusted EBITDA of $2.31 billion is a more useful profit measure than raw revenue alone when judging the business mix.

It also makes diluted adjusted EPS of $16.17 a meaningful stock metric, because per-share profit captures both operating performance and capital structure effects. Revenue of $9.86 billion gives the scale, but EPS shows how much of that scale reached shareholders in 2025.

Stock level lens

The cleanest reading for WTW stock is still numerical: $9.86 billion in 2025 revenue, $2.31 billion in adjusted EBITDA, and $16.17 in diluted adjusted EPS. Those figures form the baseline for any current valuation discussion and they define the starting point for the next earnings comparison.

Willis Towers Watson PLC remains a large-cap services business whose shares are best evaluated through earnings consistency, margin retention, and the cadence of new reporting. The next update will matter most if it changes one of those three numbers in a visible way.

Product and service mix

WTW does not depend on a single consumer product, but its service mix is still central to the investment case. Health, wealth, and career consulting together with risk and brokerage work are the operating building blocks behind the 2025 revenue of $9.86 billion and adjusted EBITDA of $2.31 billion.

That combination matters because it ties performance to corporate demand, insurance cycles, and fee-generating advisory work instead of one-off product sales. Diluted adjusted EPS of $16.17 in 2025 is the clearest shorthand for how that mix converted into shareholder earnings.

Price and valuation lens

WTW stock is listed on Nasdaq, and the company’s 2025 results provide the numbers most often used to frame valuation: $9.86 billion in revenue, $2.31 billion in adjusted EBITDA, and $16.17 in diluted adjusted EPS. Those are the figures that matter most when the market rechecks earnings quality and margin durability.

Willis Towers Watson PLC therefore remains a stock where the balance between revenue scale and profit conversion is the key issue. The 2025 baseline is already large enough to support a disciplined valuation discussion around the next reported period.